新生儿抗生素研究进展  

Progress in Neonatal Antibiotic Research

作　　者：马晓霞 李明霞[2] 

机构地区：[1]新疆医科大学儿科学院,新疆 乌鲁木齐 [2]新疆医科大学第一附属医院新生儿科,新疆 乌鲁木齐

出　　处：《临床医学进展》2024年第3期49-54,共6页Advances in Clinical Medicine

摘　　要：新生儿重症监护室(Neonatal Intensive Care Units, NICU)的抗生素治疗通常始于经验性治疗,在不同的新生儿重症监护病房中差异很大。许多研究都记录了目前NICU不必要的和长期的抗生素治疗现状及所带来的严重副作用,新生儿在生命早期暴露于抗生素会对患儿产生长期不良影响。因此,了解NICU抗生素应用现状,并采用针对性的抗生素的管理措施,希望可以提高患儿的生存质量。Antibiotic therapy in the NICU (Neonatal Intensive Care Units) usually begins empirically and varies greatly from one NICU to another. Many studies have documented the current status of unnecessary and prolonged antibiotic therapy in the NICU and the serious side effects associated with it, and that exposure of newborns to antibiotics early in life can have long-term adverse effects on the child. Therefore, understanding the current status of antibiotic use in the NICU and adopting manage-ment measures that target antibiotics will hopefully improve the quality of survival of children.

关 键 词：抗生素 新生儿 抗生素管理 抗菌素耐药性 

分 类 号：R47[医药卫生—护理学]